Artal Group S.A. - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 38 filers reported holding AC IMMUNE SA in Q4 2022. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of AC IMMUNE SA
ValueSharesWeighting
Q4 2022$2,040
-99.9%
1,000,0000.0%0.11%
-15.6%
Q3 2022$3,160,000
-12.5%
1,000,0000.0%0.14%
-30.1%
Q2 2022$3,610,000
-9.8%
1,000,0000.0%0.19%
+15.6%
Q1 2022$4,000,000
-19.2%
1,000,0000.0%0.17%
+24.6%
Q4 2021$4,950,000
-26.2%
1,000,0000.0%0.13%
-10.7%
Q3 2021$6,710,000
-15.4%
1,000,0000.0%0.15%
-6.8%
Q2 2021$7,930,000
+4.2%
1,000,0000.0%0.16%
+20.1%
Q1 2021$7,610,000
+47.2%
1,000,0000.0%0.13%
+20.7%
Q4 2020$5,170,000
+5.9%
1,000,0000.0%0.11%
-5.9%
Q3 2020$4,880,000
-26.4%
1,000,000
+1.6%
0.12%
-36.2%
Q2 2020$6,626,000
-4.1%
984,550
-1.5%
0.18%
-36.6%
Q1 2020$6,910,000
-18.9%
1,000,0000.0%0.29%
-11.2%
Q4 2019$8,520,000
+72.1%
1,000,0000.0%0.33%
+66.2%
Q3 2019$4,950,000
-10.8%
1,000,0000.0%0.20%
-11.6%
Q2 2019$5,550,000
+9.9%
1,000,0000.0%0.22%
+8.7%
Q1 2019$5,050,000
-28.8%
1,000,000
+33.3%
0.21%
-21.7%
Q4 2018$7,088,000
+18.1%
750,0000.0%0.26%
+68.6%
Q3 2018$6,000,000
+7.3%
750,000
+25.0%
0.16%
+31.1%
Q2 2018$5,592,000
-9.9%
600,0000.0%0.12%
+52.6%
Q1 2018$6,204,000
-3.1%
600,000
+20.0%
0.08%
-19.6%
Q4 2017$6,400,000
+14.6%
500,0000.0%0.10%
+1.0%
Q3 2017$5,585,000
+26.9%
500,0000.0%0.10%
+24.7%
Q2 2017$4,400,000
-15.1%
500,0000.0%0.08%
-33.0%
Q1 2017$5,180,000
+59.6%
500,000
+100.0%
0.12%
+59.7%
Q4 2016$3,245,000
+31.3%
250,000
+66.7%
0.07%
+46.9%
Q3 2016$2,471,000150,0000.05%
Other shareholders
AC IMMUNE SA shareholders Q4 2022
NameSharesValueWeighting ↓
Duquesne Family Office 1,500,000$24,705,0002.18%
Monashee Investment Management LLC 275,000$4,529,0001.59%
SPHERA FUNDS MANAGEMENT LTD. 79,800$1,314,0000.21%
Hillhouse Capital Management 550,000$9,059,0000.18%
Temasek Holdings (Private) Ltd 1,337,500$22,029,0000.18%
PointState Capital LP 425,000$7,000,0000.07%
Artal Group S.A. 150,000$2,471,0000.05%
HIGHLAND CAPITAL MANAGEMENT LP 87,900$1,448,0000.04%
Schonfeld Strategic Advisors LLC 14,779$243,0000.04%
Point72 Hong Kong Ltd 4,000$66,0000.04%
View complete list of AC IMMUNE SA shareholders